ea0081ep491 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022
Lopes Leonor
, Bello Carlos
, Limbert Maria Clotilde
, Sequeira Duarte Joao
Introduction: Sulphonylureas (SU) are an effective therapy for type 2 diabetes (T2DM). As insulin secretagogues, hypoglycemia is a potencial adverse effect. Hypoglycemia may cause neuroglycopenic brain injury, which can mimetize stroke and infections of the central nervous system. Case ReportThe authors report the case of an autonomous 71 year-old woman, with medical history of hypertension and T2DM, treated with enalapril and gliclazide, that was admitted in the Emergency Roo...